Improving enzyme efficiency for pharmaceutical production
A Data-Driven Approach to Protein Engineering of Aminotransferase ARO8
This study is all about making a key enzyme better at helping create important medicines, using smart computer techniques to find ways to improve it faster than usual.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11071483 on NIH RePORTER |
What this research studies
This research focuses on enhancing the efficiency of a specific enzyme, aminotransferase ARO8, which is crucial for producing complex pharmaceuticals. By using a data-driven approach, the researchers aim to optimize the enzyme's ability to form carbon-carbon bonds, which are essential in many drug compounds. The methodology involves computational modeling to predict beneficial mutations that can improve the enzyme's performance, thereby facilitating the development of new biocatalytic pathways. This innovative approach seeks to overcome the challenges of traditional enzyme evolution methods, which can be slow and inefficient.
Who could benefit from this research
Good fit: Patients who may benefit from this research are those requiring complex natural product-derived therapeutics, particularly in areas where current production methods are limited.
Not a fit: Patients with conditions that do not rely on biocatalytic processes for drug production may not see any direct benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and efficient production of important pharmaceuticals, potentially lowering costs and increasing availability.
How similar studies have performed: Previous research has shown promise in using data-driven approaches for enzyme optimization, indicating potential for success in this novel application.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Howard, James R — University of Utah
- Study coordinator: Howard, James R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.